3D imaging with Scaniverse to guide head and neck surgery
Official title: Digitally Acquired 3D Framework With Superimposed Preoperative Imaging Data for Intraoperative Guidance
Run by Memorial Sloan Kettering Cancer Center · NCT06676592 · Data updated 2026-11-12
This study will test whether creating 3D images from standard scans and an ultrasound using the Scaniverse app helps surgeons plan and guide head and neck surgery for adults at MSK.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 27 (estimated) |
| Sponsor | Memorial Sloan Kettering Cancer Center Academic / other |
| Drugs / interventions | radiation |
| Locations | 7 sites (Basking Ridge, New Jersey and 6 other locations) |
| Status | Recruiting |
| Started | November 1, 2024 |
| Main results expected | November 1, 2027 |
| Study ends | November 1, 2027 |
| Registry record updated | May 6, 2026 |
| Trial ID | NCT06676592 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who are scheduled for head and neck surgery within the MSK Head and Neck Service and who will have standard preoperative imaging are ideal candidates.
✕Probably not a fit
Patients with prior head and neck surgery or prior head and neck radiation are excluded and therefore would not receive benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Researchers will use the Scaniverse app during a standard preoperative ultrasound to create 3D reconstructions of the head and neck and will superimpose those reconstructions on routine imaging (CT, MRI, PET, or ultrasound) to form a combined 3D framework. Adult participants scheduled for head and neck surgery at MSK will undergo the imaging as part of their usual preoperative workup or an added research ultrasound if no standard imaging is available. Surgeons will use the 3D framework to guide anatomical orientation and surgical planning and the study will document how useful the framework is in the operative setting. The trial focuses on feasibility and clinical utility of the 3D workflow rather than testing a therapeutic device or drug.
Why it matters
Potential benefit: If successful, the technique could give surgeons a clearer, patient-specific 3D view of anatomy that may improve planning and accuracy of head and neck operations.
How similar studies have gone: Some prior work using 3D reconstructions and patient-specific models has shown promise for surgical planning, but using a consumer 3D app like Scaniverse with ultrasound for head and neck guidance is relatively novel with limited published evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged ≥18 years * Scheduled to undergo head and neck surgery in the Surgery Head and Neck Service at MSK o Note: If, for some reason, the participant is not scheduled to have standard preoperative imaging procedures, then the participant will have an ultrasound of the head and neck for research purposes. * Scheduled to undergo standard of care preoperative imaging (ie, ultrasound (US), computed tomography (CT), magnetic resonance imaging (MRI), or positron emission tomography (PET)) in the Radiology Service at MSK * Ability to understand and sign (or their legally acceptable representative (LAR) must sign) the written informed consent Exclusion Criteria: * Previous head and neck surgery or head and neck radiation * Any condition which, in the judgement of the clinical investigator or his designee, might increase the risk to the subject or decrease the chance of obtaining satisfactory data to achieve the objectives of the study
Where it's running
-
Memorial Sloan Kettering at Basking Ridge (Consent Only)
Basking Ridge, New Jersey, United States Recruiting -
Memorial Sloan Kettering Monmouth (Consent only)
Middletown, New Jersey, United States Recruiting -
Memorial Sloan Kettering Bergen (Consent only)
Montvale, New Jersey, United States Recruiting -
Memorial Sloan Kettering Suffolk - Commack (Consent only)
Commack, New York, United States Recruiting -
Memorial Sloan Kettering Westchester (Consent form)
Harrison, New York, United States Recruiting -
Memorial Sloan Kettering Cancer Center (All protocol activites)
New York, New York, United States Recruiting
Show 1 more location
-
Memorial Sloan Kettering Nassau (Consent only)
Rockville Centre, New York, United States Recruiting
Study contacts
- Principal investigator: Snehal Patel, MD — Memorial Sloan Kettering Cancer Center
- Study coordinator: Snehal Patel, MD
- Email: patels@mskcc.org
- Phone: 212-639-3412
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Bevonescein to Improve Nerve Visualization During Thyroidectomy
A new fluorescence agent called bevonescein is tested to help visualize nerves during thyroid surgery to see if it improves voice outcomes for patients with thyroid disease.
-
Retifanlimab after chemoradiation for anal cancer
This study tests whether retifanlimab can help people with anal squamous cell carcinoma who have completed chemoradiation and still have residual disease.
-
Different skin care approaches to prevent skin reactions after mastectomy radiation
This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.
-
Graft-versus-host disease after stem cell transplant: testing LBP-MARCO with ruxolitinib
We are testing whether combining LBP-MARCO with ruxolitinib is safe for adults with GVHD after a stem cell transplant.
-
68Ga-FAPI PET/MRI imaging to see if it can track breast cancer response to chemotherapy
This study tests whether a new imaging scan, 68Ga-FAPI PET/MRI, can show how well invasive breast cancer responds to neoadjuvant chemotherapy in adults.
-
Can we skip radiation after lumpectomy for low-risk HER2-positive breast cancer?
This study tests whether patients who had breast-conserving surgery and low-risk HER2-positive breast cancer can safely skip radiation therapy while receiving HER2-targeted treatment.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.